Rakhi Melvani, M.D., board-certified cornea and cataract and refractive surgeon at Gordon Schanzlin New Vision Institute, joins the Eye on Innovation podcast with host Carey Powers, M.B.A. to discuss innovative corneal treatments and how they’re changing the way patients receive treatment. Their conversation explores the FDA approval of Epioxa, an epithelium-on corneal collagen cross-linking therapy to treat progressive keratoconus, as well as refractive surgery and dry eye therapies.  

 

In this episode, learn about:  

  • Ray tracing-based customization technology and how it’s different from Lasik 
  • Collagen mimetic peptides and how they work 
  • ST100 and the patients that would benefit from it 

 

RESOURCES:  

Carey Powers: https://ois.net/carey-powers/  

Rss
Podden och tillhörande omslagsbild på den här sidan tillhör OIS Podcast. Innehållet i podden är skapat av OIS Podcast och inte av, eller tillsammans med, Poddtoppen.